Evidence map›Paper›PMID 28126309›Full record

ReviewInternational journal of radiation oncology, biology, physics2017

Smart Radiation Therapy Biomaterials.

Wilfred Ngwa, Francis Boateng, Rajiv Kumar, Darrell J Irvine, Silvia Formenti, Twalib Ngoma, Carsten Herskind, Marlon R Veldwijk, Georg Lars Hildenbrand, Michael Hausmann and 2 more

Abstract readReview
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Immunotherapies for locally aggressive cancers.Advanced drug delivery reviews · 2024
    Review
  8. Democratizing FLASH Radiotherapy.Seminars in radiation oncology · 2024
    Review
  9. Article
  10. Applications of Cannabinoids in Neuropathic Pain: An Updated Review.Critical reviews in therapeutic drug carrier systems · 2024
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes.International journal of radiation oncology, biology, physics · 2022
    Article
  18. Article
  19. Surface Modification of Bacterial Cellulose for Biomedical Applications.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 3 countries.

Wilfred NgwaDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Physics and Applied Physics, University of Massachusetts, Lowell, Massachusetts. Electronic address: wngwa@lroc.harvard.edu.
Francis BoatengDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Rajiv KumarDepartment of Physics, Northeastern University, Dana-Farber Cancer Institute, Massachusetts.
Darrell J IrvineDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Silvia FormentiDepartment of Radiation Oncology, Cornell University, Ithaca, New York.
Twalib NgomaDepartment of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Tanzania.
Carsten HerskindUniversity Medical Center Mannheim, University of Heidelberg, Germany.
Marlon R VeldwijkUniversity Medical Center Mannheim, University of Heidelberg, Germany.
Georg Lars HildenbrandUniversity Medical Center Mannheim, University of Heidelberg, Germany.
Michael HausmannKirchhoff-Institute for Physics, University of Heidelberg, Germany.
Frederik WenzUniversity Medical Center Mannheim, University of Heidelberg, Germany.
Juergen HesserUniversity Medical Center Mannheim, University of Heidelberg, Germany.
University Hospital Heidelberg · DEUniversity Medical Centre Mannheim · DEBrigham and Women's Hospital · USCornell University · USHarvard University · USHeidelberg University · DEKirchhoff (Germany) · DEMassachusetts Institute of Technology · USMuhimbili University of Health and Allied Sciences · TZNortheastern University · US

Funding

Brachytherapy in situ dose-painting administered via gold-nanoparticle elutersK01CA172478 · NCI · DANA-FARBER CANCER INST · PI NGWA, WILFRED · 2013 to 2017
$883k
NCI NIH HHS K01 CA172478
6 · The paper itself

Abstract

Radiation therapy (RT) is a crucial component of cancer care, used in the treatment of over 50% of cancer patients. Patients undergoing image guided RT or brachytherapy routinely have inert RT biomaterials implanted into their tumors. The single function of these RT biomaterials is to ensure geometric accuracy during treatment. Recent studies have proposed that the inert biomaterials could be upgraded to "smart" RT biomaterials, designed to do more than 1 function. Such smart biomaterials include next-generation fiducial markers, brachytherapy spacers, and balloon applicators, designed to respond to stimuli and perform additional desirable functions like controlled delivery of therapy-enhancing payloads directly into the tumor subvolume while minimizing normal tissue toxicities. More broadly, smart RT biomaterials may include functionalized nanoparticles that can be activated to boost RT efficacy. This work reviews the rationale for smart RT biomaterials, the state of the art in this emerging cross-disciplinary research area, challenges and opportunities for further research and development, and a purview of potential clinical applications. Applications covered include using smart RT biomaterials for boosting cancer therapy with minimal side effects, combining RT with immunotherapy or chemotherapy, reducing treatment time or health care costs, and other incipient applications.

Indexed as

Fiducial MarkersArtificial IntelligenceBiocompatible MaterialsBrachytherapyHumansNanoparticlesRadiotherapy, Image-GuidedBiocompatible Materials

Identifiers

PMID28126309
PMCPMC5302132
OpenAlexW2548760197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.